Govt Job: For Scientists at United States Pharmacopeia (USP)

Apply Online

United States Pharmacopeia (USP) is proud to be an equal opportunity / affirmative action employer. Employment selection and related decisions are made without regard to sex, gender identity, race, age, disability, religion, national origin, color, veteran status or any other protected class.

We are committed to working with and providing reasonable accommodation to individuals with disabilities.

Post : Scientist III / Senior Scientist I CDL

Job Description
• Search relevant literature for the USP/NF monograph modernization projects.

• Responsible for the modernization / development project (initiation, execution, reporting, & completion).

• Should have worked on chromatography (HPLC, GC), mass spectrometry (LC- MS/MS, GC- MS/MS) techniques.

• Should have experience of method development and validations (DS/DP/Excipients).

• Responsible for design, review, and execution of method development experiments and perform method validation in accordance with laid down procedure.

• Responsible for preparation of method validation protocols and reports.

• Plan individually the project requirements and their completion within the time lines by coordinating with the supervisor.

• Responsible for procurement of chemicals, reagents, glassware, columns, project related samples, and general requirement on regular basis.

• Responsible for preparing regular project updates and communicating with internal customers through verbal and email communication.

• Responsible for preparation and review of SOPs, protocols, reports and ELNs.

• Responsible for instrument maintenance and ensuring good lab practices.

• Ensure that the calibrations of the equipment are performed as per the schedule.

• Responsible for review of IQ/OQ/PQ documents of instruments.

• Coordinate with supervisor for internal audits, ISO17025 and ISO9001.

• Maintain GLP & safety procedures while working in Lab.

Candidate Profile
• Master’s degree in Chemistry or relevant field.

• Minimum of 8-10 years (Senior Scientist I) or 5-7 years (Scientist III) of experience in the field of analytical method development and validations.

• Master’s Degree in Chemistry (Analytical / Organic) or Pharmaceutical Sciences with 8-10 years (Senior Scientist I) or 5-7 years (Scientist III) years of experience or PhD with at least 3-4 years of experience in relevant field.

• A candidate with an experience of analyzing genotoxic impurities (such nitrosamines) using LC-MS-MS and GC-MS-MS will be preferred

• Knowledge and exposure of analytical QbD approach.

• Excellent written and verbal communications skills.

• Technical and analytical skills required including the ability to interpret technical information.

• Must have hands on experience on handling instruments like HPLC, UHPLC, LC-MS, GC, GC-MS, IC, ICP-OES/MS, FTIR, UV-Visible etc.

• Must have experience of working in GMP environment and have exposure of regulatory guidelines.

• Ability to handle multiple priorities in a fast-paced environment.

Additional Information
Location :  Hyderabad, India
Industry Type : Pharma
Functional Area :  CDL
End Date : 30th Januaray, 2022

Related Posts

  • Pharma
  • June 24, 2025
  • 64 views
Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharmaceuticals announced that it had launched TEVIMBRA (tislelizumab) in India after receiving approval from the Central Drugs Standard Control Organization (CDSCO). The drug is a specially designed anti-PD-1 monoclonal…

  • Pharma
  • June 24, 2025
  • 71 views
India’s herbal and ayurvedic OTC market set to outpace global growth

New Delhi: India’s herbal and ayurvedic OTC (over the counter) market is expected to grow at a CAGR of 6.5 per cent, from $69 million in 2025 to $118 million…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharma launches TEVIMBRA in India

India’s herbal and ayurvedic OTC market set to outpace global growth

India’s herbal and ayurvedic OTC market set to outpace global growth

Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug